Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2016 | 06-2016 | 05-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110 | 18 | N/A | 34 | N/A |
| Receivables | 1,521 | N/A | N/A | N/A | N/A |
| Other current assets | 785 | 0 | 0 | 0 | 0 |
| TOTAL | $2,573 | $18 | $N/A | $34 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 319 | N/A | N/A | N/A | N/A |
| Intangibles | 0 | 14 | 0 | 14 | 0 |
| TOTAL | $319 | $14 | $N/A | $14 | $N/A |
| Total Assets | $2,891 | $31 | $N/A | $47 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,879 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,035 | 9 | 0 | 27 | 0 |
| Accrued Expenses | 1,068 | N/A | N/A | N/A | N/A |
| Other current liabilities | 1,839 | N/A | N/A | N/A | N/A |
| TOTAL | $9,968 | $9 | $N/A | $27 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 12 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 6 | 0 | 2 | 0 | 0 |
| TOTAL | $12 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,980 | $9 | $N/A | $27 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 2,246 | N/A | 2,231 | 2,206 |
| Common Shares | 0 | 23 | N/A | 22 | N/A |
| Retained earnings | -8,354 | -22,308 | N/A | -22,291 | N/A |
| Other shareholders' equity | 1,265 | 0 | 0 | 0 | 0 |
| TOTAL | $-7,089 | $22 | $N/A | $20 | $N/A |
| Total Liabilities And Equity | $2,891 | $31 | $0 | $47 | $0 |